Published in Optom Vis Sci on June 01, 2008
Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons. Mol Neurodegener (2011) 1.05
Neuroprotection for treatment of glaucoma in adults. Cochrane Database Syst Rev (2010) 1.03
Resveratrol prevents the expression of glaucoma markers induced by chronic oxidative stress in trabecular meshwork cells. Food Chem Toxicol (2008) 0.98
Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases. Mediators Inflamm (2015) 0.96
Imaging apoptosis in the eye. Eye (Lond) (2011) 0.96
Current primary open-angle glaucoma treatments and future directions. Clin Ophthalmol (2012) 0.93
Using genetic mouse models to gain insight into glaucoma: Past results and future possibilities. Exp Eye Res (2015) 0.88
Distribution and dynamics of adamantanes in a lipid bilayer. Biophys J (2008) 0.88
Neuroprotection for treatment of glaucoma in adults. Cochrane Database Syst Rev (2013) 0.85
Glaucoma-induced degeneration of retinal ganglion cells prevented by hypoxic preconditioning: a model of glaucoma tolerance. Mol Med (2012) 0.84
Somatic comorbidities and Alzheimer's disease treatment. Neurol Sci (2013) 0.83
Nutrient intake and risk of open-angle glaucoma: the Rotterdam Study. Eur J Epidemiol (2012) 0.83
Role of microglia adenosine A(2A) receptors in retinal and brain neurodegenerative diseases. Mediators Inflamm (2014) 0.80
Neuroprotection for treatment of glaucoma in adults. Cochrane Database Syst Rev (2017) 0.78
Cytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives. Int J Mol Sci (2015) 0.77
Rationale for the use of multifunctional drugs as neuroprotective agents for glaucoma. Neural Regen Res (2012) 0.76
Bis(7)-tacrine protects retinal ganglion cells against excitotoxicity via NMDA receptor inhibition. Int J Ophthalmol (2011) 0.76
Retinal protective effects of topically administered agmatine on ischemic ocular injury caused by transient occlusion of the ophthalmic artery. Braz J Med Biol Res (2012) 0.76
Neuroprotective Effects of Memantine in the Retina of Glaucomatous Rats: An Electron Microscopic Study. J Ophthalmic Vis Res (2016) 0.75
Oral Delivery of a Synthetic Sterol Reduces Axonopathy and Inflammation in a Rodent Model of Glaucoma. Front Neurosci (2017) 0.75
Determination of Serum Ceruloplasmin Concentration in Patients with Primary Open Angle Glaucoma with Cataract and Patients with Cataract Only: A Pilot Study. Med Sci Monit (2016) 0.75
Glaucoma: Biological Trabecular and Neuroretinal Pathology with Perspectives of Therapy Innovation and Preventive Diagnosis. Front Neurosci (2017) 0.75
Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol (2000) 20.70
Number of people with glaucoma worldwide. Br J Ophthalmol (1996) 14.31
Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature (1987) 8.89
Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol (2003) 8.76
Glutamate neurotoxicity and diseases of the nervous system. Neuron (1988) 8.26
Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol (1998) 7.34
Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med (1994) 6.77
The impact of ocular blood flow in glaucoma. Prog Retin Eye Res (2002) 5.76
High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature (1991) 4.44
Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res (2004) 3.75
Amyloidosis. Annu Rev Med (2006) 3.27
Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke (1997) 3.26
Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat Med (1999) 3.13
Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci (1990) 2.98
Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science (1989) 2.77
The Alzheimer's A beta -peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci U S A (2002) 2.74
The trkB tyrosine protein kinase is a receptor for brain-derived neurotrophic factor and neurotrophin-3. Cell (1991) 2.56
Tumor necrosis factor-alpha expression in ischemic neurons. Stroke (1994) 2.37
The role of oxidative stress in glaucoma. Mutat Res (2006) 2.28
Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. J Neurosci (1992) 2.25
Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol (2004) 2.19
Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death. J Neurosci (2004) 2.17
Mammalian neurotrophin-4: structure, chromosomal localization, tissue distribution, and receptor specificity. Proc Natl Acad Sci U S A (1992) 2.14
The chemical biology of clinically tolerated NMDA receptor antagonists. J Neurochem (2006) 2.13
Visual field defects and neural losses from experimental glaucoma. Prog Retin Eye Res (2002) 2.05
TNF-alpha and TNF-alpha receptor-1 in the retina of normal and glaucomatous eyes. Invest Ophthalmol Vis Sci (2001) 2.04
Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc Natl Acad Sci U S A (2004) 1.90
Mitochondrial abnormalities in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci (2006) 1.84
Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest Ophthalmol Vis Sci (2002) 1.82
Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma. Am J Ophthalmol (2003) 1.79
NMDA receptor antagonists. A new therapeutic approach for Alzheimer's disease. Geriatrics (2004) 1.79
Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci U S A (2007) 1.77
Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model. Invest Ophthalmol Vis Sci (2000) 1.68
The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch Ophthalmol (1957) 1.67
Protective autoimmunity is a physiological response to CNS trauma. J Neurosci (2001) 1.64
Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol (1996) 1.64
Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease. J Neuroophthalmol (2006) 1.63
Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion. J Neurosci (2000) 1.62
T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies. Proc Natl Acad Sci U S A (2000) 1.61
Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma. Proc Natl Acad Sci U S A (2001) 1.61
Morphological and functional retinal impairment in Alzheimer's disease patients. Clin Neurophysiol (2001) 1.59
Neuroprotection in relation to retinal ischemia and relevance to glaucoma. Surv Ophthalmol (1999) 1.58
Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke (2002) 1.57
Pharmacological neuroprotection for glaucoma. Drugs (2007) 1.56
Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons. Proc Natl Acad Sci U S A (2000) 1.51
Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia. Mol Med (1997) 1.51
Retinal pathology in Alzheimer's disease. I. Ganglion cell loss in foveal/parafoveal retina. Neurobiol Aging (1996) 1.46
Can chronic increased intracranial pressure or exposure to repetitive intermittent intracranial pressure elevations raise your risk for Alzheimer's disease? Med Hypotheses (2004) 1.45
Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies. Neurochem Int (2007) 1.45
Caspase-independent component of retinal ganglion cell death, in vitro. Invest Ophthalmol Vis Sci (2004) 1.38
Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo. Invest Ophthalmol Vis Sci (2006) 1.37
Dominant-interfering forms of MEF2 generated by caspase cleavage contribute to NMDA-induced neuronal apoptosis. Proc Natl Acad Sci U S A (2002) 1.35
Synaptic localization of NMDA receptor subunits in the rat retina. J Comp Neurol (2000) 1.34
Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol (2002) 1.34
Systemic reduction in glutathione levels occurs in patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci (2005) 1.34
Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10. Toxicol Appl Pharmacol (2004) 1.33
A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500). Int Clin Psychopharmacol (2002) 1.29
Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model. Invest Ophthalmol Vis Sci (2003) 1.29
Neuroprotection by memantine against neurodegeneration induced by beta-amyloid(1-40). Brain Res (2002) 1.29
Retinal pathology in Alzheimer's disease. II. Regional neuron loss and glial changes in GCL. Neurobiol Aging (1996) 1.28
Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes. Arch Ophthalmol (2000) 1.26
Vitreous fluid levels of beta-amyloid((1-42)) and tau in patients with retinal diseases. Jpn J Ophthalmol (2005) 1.26
Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. J Biol Chem (2003) 1.25
Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels. Eur J Pharmacol (1989) 1.18
Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures. Invest Ophthalmol Vis Sci (2004) 1.17
Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures. Invest Ophthalmol Vis Sci (2004) 1.17
Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine. Nature (1970) 1.15
Assessment of rat and mouse RGC apoptosis imaging in vivo with different scanning laser ophthalmoscopes. Curr Eye Res (2007) 1.15
Immunoreactivity against tau, amyloid precursor protein, and beta-amyloid in the human retina. Invest Ophthalmol Vis Sci (1995) 1.14
Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration. FEBS Lett (2004) 1.13
The effects of antiglaucoma and systemic medications on ocular blood flow. Prog Retin Eye Res (2003) 1.13
Müller cell response to laser-induced increase in intraocular pressure in rats. Glia (2004) 1.11
Role of caspases in N-methyl-D-aspartate-induced apoptosis in cerebrocortical neurons. J Neurochem (1998) 1.11
Selective excitotoxic degeneration of adult pig retinal ganglion cells in vitro. Invest Ophthalmol Vis Sci (2001) 1.10
Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma. Arch Ophthalmol (2006) 1.08
Differential T cell response in central and peripheral nerve injury: connection with immune privilege. FASEB J (1999) 1.08
Calcium, free radicals and excitotoxins in neuronal apoptosis. Cell Calcium (1998) 1.08
Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes. Neurochem Res (2006) 1.07
Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide. Trends Neurosci (1993) 1.07
Retinal ganglion cells and neuroprotection for glaucoma. Surv Ophthalmol (2003) 1.06
Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage. Surv Ophthalmol (2003) 1.06
Retinal damage caused by high intraocular pressure-induced transient ischemia is prevented by coenzyme Q10 in rat. Int Rev Neurobiol (2007) 1.05
Glutaate-induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion. J Neuropathol Exp Neurol (1969) 1.05
Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model. Vision Res (2002) 1.05
Recruitment of NF-kappaB into mitochondria is involved in adenine nucleotide translocase 1 (ANT1)-induced apoptosis. J Biol Chem (2004) 1.04
Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson's disease. J Neural Transm Park Dis Dement Sect (1992) 1.04
Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat. Invest Ophthalmol Vis Sci (2002) 1.04
Dynamic changes in reactive oxygen species and antioxidant levels in retinas in experimental glaucoma. Free Radic Biol Med (2005) 1.03
Retinal ganglion cells, glaucoma and neuroprotection. Prog Brain Res (2001) 1.01
Expression of NMDA and high-affinity kainate receptor subunit mRNAs in the adult rat retina. Eur J Neurosci (1994) 1.00
Glaucoma neuroprotection: What is it? Why is it needed? Can J Ophthalmol (2007) 1.00
Memantine is neuroprotective in a rat model of pressure-induced retinal ischemia. Invest Ophthalmol Vis Sci (1998) 0.99
Pharmacotherapeutic approaches to the treatment of Alzheimer's disease. Clin Ther (2004) 0.98
Neuroprotective effect of memantine in different retinal injury models in rats. J Glaucoma (2002) 0.98
Neuroprotective effect of memantine in a rabbit model of optic nerve ischemia. Korean J Ophthalmol (2002) 0.97
Enhanced survival and regeneration of axotomized retinal ganglion cells by a mixture of herbal extracts. J Neurotrauma (2002) 0.97
[Effects of oral memantine administration on Parkinson symptoms. Results of a placebo-controlled multicenter study]. Dtsch Med Wochenschr (1984) 0.96
Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy. Arch Ophthalmol (2003) 0.94
Evoked expression of the glutamate transporter GLT-1c in retinal ganglion cells in human glaucoma and in a rat model. Invest Ophthalmol Vis Sci (2006) 0.94
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. Nat Biotechnol (2010) 7.08
Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54. Nat Genet (2010) 2.95
Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci (2005) 2.02
Neuroprotection in glaucoma - Is there a future role? Exp Eye Res (2010) 1.97
Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration. Proc Natl Acad Sci U S A (2004) 1.90
Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci U S A (2007) 1.77
Cystic bleb formation and related complications in limbus- versus fornix-based conjunctival flaps in pediatric and young adult trabeculectomy with mitomycin C. Ophthalmology (2003) 1.65
CKAP4/p63 is a receptor for the frizzled-8 protein-related antiproliferative factor from interstitial cystitis patients. J Biol Chem (2006) 1.44
Prevalence and risk factors of urinary incontinence for post-stroke inpatients in Southern China. Neurourol Urodyn (2013) 1.42
Expression and significance of vascular endothelial growth factor A and C in leukemia central nervous system metastasis. Leuk Res (2012) 1.40
LPS up-regulates mucin and cytokine mRNA expression and stimulates mucin and cytokine secretion in goblet cells. Cell Immunol (2003) 1.38
Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo. Invest Ophthalmol Vis Sci (2006) 1.37
Evaluation of anti-TGF-beta2 antibody as a new postoperative anti-scarring agent in glaucoma surgery. Invest Ophthalmol Vis Sci (2003) 1.33
Analysis of hemagglutinin-mediated entry tropism of H5N1 avian influenza. Virol J (2009) 1.33
Genotypic variants at 2q33 and risk of esophageal squamous cell carcinoma in China: a meta-analysis of genome-wide association studies. Hum Mol Genet (2012) 1.28
Human antitransforming growth factor beta(2) monoclonal antibody--a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study. Ophthalmology (2002) 1.26
Analysis of serum genome-wide microRNAs for breast cancer detection. Clin Chim Acta (2012) 1.25
Unexpected low-dose toxicity of the universal solvent DMSO. FASEB J (2013) 1.24
Requirement of dendritic Akt degradation by the ubiquitin-proteasome system for neuronal polarity. J Cell Biol (2006) 1.20
Crystal structure of human enterovirus 71 3C protease. J Mol Biol (2011) 1.20
Human antibody responses to avian influenza A(H7N9) virus, 2013. Emerg Infect Dis (2014) 1.19
Preparation of DNA ladder based on multiplex PCR technique. J Nucleic Acids (2010) 1.17
Next-generation sequencing of microRNAs for breast cancer detection. J Biomed Biotechnol (2011) 1.17
SLC25A13 gene analysis in citrin deficiency: sixteen novel mutations in East Asian patients, and the mutation distribution in a large pediatric cohort in China. PLoS One (2013) 1.16
Assessment of rat and mouse RGC apoptosis imaging in vivo with different scanning laser ophthalmoscopes. Curr Eye Res (2007) 1.15
An animal model of SARS produced by infection of Macaca mulatta with SARS coronavirus. J Pathol (2005) 1.12
Crystal structures of enterovirus 71 3C protease complexed with rupintrivir reveal the roles of catalytically important residues. J Virol (2011) 1.12
Revealing the essentiality of multiple archaeal pcna genes using a mutant propagation assay based on an improved knockout method. Microbiology (2010) 1.11
Genotypic and phenotypic features of citrin deficiency: five-year experience in a Chinese pediatric center. Int J Mol Med (2011) 1.10
Real-time in vivo imaging of retinal cell apoptosis after laser exposure. Invest Ophthalmol Vis Sci (2008) 1.06
Tracking longitudinal retinal changes in experimental ocular hypertension using the cSLO and spectral domain-OCT. Invest Ophthalmol Vis Sci (2010) 1.04
Assessment of neuroprotection in the retina with DARC. Prog Brain Res (2008) 1.01
Shell distribution on colloidal CdSe/ZnS quantum dots. Nano Lett (2005) 1.01
Genome-wide analysis of mir-548 gene family reveals evolutionary and functional implications. J Biomed Biotechnol (2012) 0.99
Localisation and significance of in vivo near-infrared autofluorescent signal in retinal imaging. Br J Ophthalmol (2010) 0.98
Functionalization of alpha,beta-unsaturated esters and ketones: a facile and highly stereoselective one-pot approach to N-protected alpha,beta-dehydroamino acid derivatives. Org Lett (2005) 0.98
Structure-activity relationship studies for the peptide portion of the bladder epithelial cell antiproliferative factor from interstitial cystitis patients. J Med Chem (2008) 0.98
Cellular immune dysfunction in immune thrombocytopenia (ITP). Br J Haematol (2013) 0.98
Sulforaphane ameliorates the development of experimental autoimmune encephalomyelitis by antagonizing oxidative stress and Th17-related inflammation in mice. Exp Neurol (2013) 0.98
Preservative-free treatment in glaucoma: who, when, and why. Eur J Ophthalmol (2013) 0.97
Cathepsin K in adipocyte differentiation and its potential role in the pathogenesis of obesity. J Clin Endocrinol Metab (2006) 0.96
Polymorphism of the DNA repair gene ERCC2 Lys751Gln and risk of lung cancer in a northeastern Chinese population. Cancer Genet Cytogenet (2006) 0.96
Cervical human papillomavirus screening among older women. Emerg Infect Dis (2005) 0.96
Pharmacodynamic action and mechanism of volatile oil from Rhizoma Ligustici Chuanxiong Hort. on treating headache. Phytomedicine (2009) 0.95
Genetic variability of Echinococcus granulosus from the Tibetan plateau inferred by mitochondrial DNA sequences. Vet Parasitol (2013) 0.94
Ocular manifestations of Alzheimer's disease in animal models. Int J Alzheimers Dis (2012) 0.94
Maternal plasma miRNAs expression in preeclamptic pregnancies. Biomed Res Int (2013) 0.93
Large-scale seroprevalence analysis of human metapneumovirus and human respiratory syncytial virus infections in Beijing, China. Virol J (2011) 0.92
Accuracy of intraocular pressure measurements in new zealand white rabbits. Invest Ophthalmol Vis Sci (2005) 0.92
Combining phacoemulsification with endoscopic cyclophotocoagulation to manage cataract and glaucoma. Clin Experiment Ophthalmol (2013) 0.91
Ultrasonography-guided percutaneous microwave ablation of peripheral lung cancer. Clin Imaging (2006) 0.91
Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells. J Exp Clin Cancer Res (2010) 0.91
Identification of a highly conserved H1 subtype-specific epitope with diagnostic potential in the hemagglutinin protein of influenza A virus. PLoS One (2011) 0.90
Expression of metalloproteinases from human retinal pigment epithelial cells and their effects on the hydraulic conductivity of Bruch's membrane. Invest Ophthalmol Vis Sci (2002) 0.90
Dendritic changes in visual pathways in glaucoma and other neurodegenerative conditions. Exp Eye Res (2011) 0.90
Inhibition of iNOS protects endothelial-dependent vasodilation in aged rats. Acta Pharmacol Sin (2010) 0.90
Genetic analysis of 15 STR loci from a Xibe population in Liaoning, Northeast of China. Ann Hum Biol (2013) 0.90
Optical coherence tomography in anterior segment imaging. Acta Ophthalmol Scand (2007) 0.89
Ultrabright PbSe magic-sized clusters. Nano Lett (2008) 0.88
Allele frequencies of 19 autosomal STR loci in Manchu population of China with phylogenetic structure among worldwide populations. Gene (2013) 0.88
Allele frequencies of 6 autosomal STR loci in the Xibo nationality with phylogenetic structure among Chinese populations. Gene (2011) 0.88
Lack of association between DNA repair gene ERCC1 polymorphism and risk of lung cancer in a Chinese population. Cancer Genet Cytogenet (2006) 0.87
Algorithms of GPU-enabled reactive force field (ReaxFF) molecular dynamics. J Mol Graph Model (2013) 0.87
Mutation spectrum of the CFTR gene in Taiwanese patients with congenital bilateral absence of the vas deferens. Hum Reprod (2005) 0.86
Chromatin-bound NLS proteins recruit membrane vesicles and nucleoporins for nuclear envelope assembly via importin-α/β. Cell Res (2012) 0.86
Species delimitation and historical biogeography in the genus Helice (Brachyura: Varunidae) in the northwestern Pacific. Zoolog Sci (2009) 0.85
Structural insights into the interaction of the crenarchaeal chromatin protein Cren7 with DNA. Mol Microbiol (2010) 0.85
A snapshot of the status of problem-based learning (PBL) in Chinese medical schools. Med Teach (2014) 0.85
Induction of cortical cataracts in cultured mouse lenses with H-89, an inhibitor of protein kinase A. Curr Eye Res (2003) 0.85
atBioNet--an integrated network analysis tool for genomics and biomarker discovery. BMC Genomics (2012) 0.85
A semi-automated technique for labeling and counting of apoptosing retinal cells. BMC Bioinformatics (2014) 0.85
Complete genome sequence and pathogenesis of bovine viral diarrhea virus JL-1 isolate from cattle in China. Virol J (2014) 0.84
Chemical composition and antibacterial activity of essential oils from different parts of Leonurus japonicus Houtt. Molecules (2013) 0.84
New trends in glaucoma risk, diagnosis & management. Indian J Med Res (2013) 0.84
Psychopathological, biological, and neuroimaging characterization of posttraumatic stress disorder in survivors of a severe coalmining disaster in China. J Psychiatr Res (2009) 0.84
Clinical evidence for neuroprotection in glaucoma. Am J Ophthalmol (2011) 0.84
The role of insulin-like growth factor I and hypoxia inducible factor 1α in vascular endothelial growth factor expression in type 2 diabetes. Ann Clin Lab Sci (2013) 0.84
The soluble VEGF receptor 1 and 2 expression in cerebral spinal fluid as an indicator for leukemia central nervous system metastasis. J Neurooncol (2013) 0.83
Presence of mutation m.14484T>C in a Chinese family with maternally inherited essential hypertension but no expression of LHON. Biochim Biophys Acta (2012) 0.83
Effects of 3, 5, 3'-triiodothyronine (t3) and follicle stimulating hormone on apoptosis and proliferation of rat ovarian granulosa cells. Chin J Physiol (2013) 0.83
Bupleurum polysaccharides attenuates lipopolysaccharide-induced inflammation via modulating Toll-like receptor 4 signaling. PLoS One (2013) 0.83
Focus on: amyloid beta. Exp Eye Res (2009) 0.83
Bocavirus in children with respiratory tract infections. Emerg Infect Dis (2011) 0.83
Purification of annexin V and its use in the detection of apoptotic cells. Methods Mol Biol (2011) 0.83
Prime immunization with rotavirus VLP 2/6 followed by boosting with an adenovirus expressing VP6 induces protective immunization against rotavirus in mice. Virol J (2011) 0.83
Neuroprotective effects of VEGF administration after focal cerebral ischemia/reperfusion: dose response and time window. Neurochem Int (2012) 0.83
A comprehensive survey of maternal plasma miRNAs expression profiles using high-throughput sequencing. Clin Chim Acta (2011) 0.82
Apoptosis induced by the SARS-associated coronavirus in Vero cells is replication-dependent and involves caspase. DNA Cell Biol (2005) 0.82
[The SNPs analysis of encoding sequence of interacting factor gene in Chinese population]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (2003) 0.82
Constructing a robust protein-protein interaction network by integrating multiple public databases. BMC Bioinformatics (2011) 0.82
Electroretinogram and visual-evoked potential assessment of retinal and central visual function in a rat ocular hypertension model of glaucoma. Curr Eye Res (2013) 0.82
Identification and characterization of small RNAs in the hyperthermophilic archaeon Sulfolobus solfataricus. PLoS One (2012) 0.82